

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.17813014 |
| 2 | signal peptide processing (GO:0006465) | 5.80225880 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.54419451 |
| 4 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.97305776 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.96908495 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.96908495 |
| 7 | positive regulation of granulocyte differentiation (GO:0030854) | 4.79759170 |
| 8 | positive regulation of B cell differentiation (GO:0045579) | 4.62611738 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.52935161 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46861583 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.45380761 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.43609721 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.29662736 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 4.24668811 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.15501234 |
| 16 | regulation of B cell differentiation (GO:0045577) | 4.13284420 |
| 17 | negative T cell selection (GO:0043383) | 4.06241714 |
| 18 | positive T cell selection (GO:0043368) | 4.01485610 |
| 19 | negative thymic T cell selection (GO:0045060) | 3.96334741 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.92987298 |
| 21 | endocrine pancreas development (GO:0031018) | 3.86290945 |
| 22 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.76887051 |
| 23 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.68078928 |
| 24 | response to interleukin-15 (GO:0070672) | 3.67394307 |
| 25 | regulation of tolerance induction (GO:0002643) | 3.62231134 |
| 26 | defense response to protozoan (GO:0042832) | 3.60134379 |
| 27 | regulation of hexokinase activity (GO:1903299) | 3.59273581 |
| 28 | regulation of glucokinase activity (GO:0033131) | 3.59273581 |
| 29 | photoreceptor cell maintenance (GO:0045494) | 3.58397982 |
| 30 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.54413723 |
| 31 | Peyers patch development (GO:0048541) | 3.54413723 |
| 32 | leukocyte aggregation (GO:0070486) | 3.54205687 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.52471520 |
| 34 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.52111756 |
| 35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.42447765 |
| 36 | cellular response to interleukin-15 (GO:0071350) | 3.41314774 |
| 37 | megakaryocyte development (GO:0035855) | 3.38409026 |
| 38 | T cell selection (GO:0045058) | 3.37429075 |
| 39 | positive regulation of interleukin-17 production (GO:0032740) | 3.36001814 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.34761697 |
| 41 | regulation of interleukin-17 production (GO:0032660) | 3.31545516 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.30743078 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 3.30743078 |
| 44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.30743078 |
| 45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.30743078 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.30743078 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.30743078 |
| 48 | regulation of T cell tolerance induction (GO:0002664) | 3.30635475 |
| 49 | glandular epithelial cell differentiation (GO:0002067) | 3.30559722 |
| 50 | regulation of granulocyte differentiation (GO:0030852) | 3.30529997 |
| 51 | response to protozoan (GO:0001562) | 3.27912389 |
| 52 | definitive hemopoiesis (GO:0060216) | 3.26247485 |
| 53 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.25373838 |
| 54 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.25238561 |
| 55 | tolerance induction (GO:0002507) | 3.23302787 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22917559 |
| 57 | nucleotide transmembrane transport (GO:1901679) | 3.22711826 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 3.20965455 |
| 59 | cellular extravasation (GO:0045123) | 3.20157343 |
| 60 | activated T cell proliferation (GO:0050798) | 3.19689135 |
| 61 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.19669309 |
| 62 | positive regulation of tolerance induction (GO:0002645) | 3.17429241 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16633021 |
| 64 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.16314922 |
| 65 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.16079813 |
| 66 | eye photoreceptor cell development (GO:0042462) | 3.15430439 |
| 67 | photoreceptor cell development (GO:0042461) | 3.14239678 |
| 68 | rhodopsin mediated signaling pathway (GO:0016056) | 3.13345909 |
| 69 | thymic T cell selection (GO:0045061) | 3.12736201 |
| 70 | mast cell degranulation (GO:0043303) | 3.12694833 |
| 71 | mast cell activation involved in immune response (GO:0002279) | 3.12694833 |
| 72 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.10023856 |
| 73 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.10023856 |
| 74 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.09695841 |
| 75 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.06925040 |
| 76 | peptide hormone processing (GO:0016486) | 3.06513033 |
| 77 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.05739405 |
| 78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.04850115 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 3.04645710 |
| 80 | leukocyte degranulation (GO:0043299) | 3.03651640 |
| 81 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.02358642 |
| 82 | regulation of alpha-beta T cell activation (GO:0046634) | 3.02350057 |
| 83 | detection of light stimulus involved in visual perception (GO:0050908) | 3.02231236 |
| 84 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.02231236 |
| 85 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.02071427 |
| 86 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00887379 |
| 87 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.00263423 |
| 88 | regulation of regulatory T cell differentiation (GO:0045589) | 3.00211084 |
| 89 | B cell mediated immunity (GO:0019724) | 2.99411100 |
| 90 | mature B cell differentiation involved in immune response (GO:0002313) | 2.99017729 |
| 91 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.98264409 |
| 92 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97789155 |
| 93 | dendritic cell chemotaxis (GO:0002407) | 2.96398017 |
| 94 | negative regulation of interleukin-17 production (GO:0032700) | 2.95883096 |
| 95 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95727359 |
| 96 | regulation of germinal center formation (GO:0002634) | 2.95551453 |
| 97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.93279046 |
| 98 | positive regulation of insulin secretion (GO:0032024) | 2.93091298 |
| 99 | neutrophil activation (GO:0042119) | 2.91532528 |
| 100 | natural killer cell activation involved in immune response (GO:0002323) | 2.91393104 |
| 101 | nucleoside diphosphate catabolic process (GO:0009134) | 2.87302417 |
| 102 | positive regulation of mast cell activation (GO:0033005) | 2.84758312 |
| 103 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84635331 |
| 104 | negative regulation of T cell apoptotic process (GO:0070233) | 2.83734497 |
| 105 | eosinophil chemotaxis (GO:0048245) | 2.82731925 |
| 106 | peptidyl-histidine modification (GO:0018202) | 2.82595380 |
| 107 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82080903 |
| 108 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82080903 |
| 109 | regulation of mast cell degranulation (GO:0043304) | 2.81141996 |
| 110 | negative regulation of viral genome replication (GO:0045071) | 2.81104261 |
| 111 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.80499924 |
| 112 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.80328199 |
| 113 | T cell receptor signaling pathway (GO:0050852) | 2.80215065 |
| 114 | response to type I interferon (GO:0034340) | 2.78976235 |
| 115 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.77984930 |
| 116 | cellular response to type I interferon (GO:0071357) | 2.77940955 |
| 117 | type I interferon signaling pathway (GO:0060337) | 2.77940955 |
| 118 | ER overload response (GO:0006983) | 2.77836580 |
| 119 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.77482587 |
| 120 | mature B cell differentiation (GO:0002335) | 2.77476644 |
| 121 | regulation of mast cell activation (GO:0033003) | 2.76220275 |
| 122 | platelet dense granule organization (GO:0060155) | 2.74967072 |
| 123 | response to peptidoglycan (GO:0032494) | 2.74271263 |
| 124 | superoxide anion generation (GO:0042554) | 2.72956385 |
| 125 | insulin secretion (GO:0030073) | 2.71806001 |
| 126 | cytochrome complex assembly (GO:0017004) | 2.71422431 |
| 127 | dentate gyrus development (GO:0021542) | 2.70974837 |
| 128 | daunorubicin metabolic process (GO:0044597) | 2.70738653 |
| 129 | polyketide metabolic process (GO:0030638) | 2.70738653 |
| 130 | doxorubicin metabolic process (GO:0044598) | 2.70738653 |
| 131 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.70084270 |
| 132 | mast cell activation (GO:0045576) | 2.69894940 |
| 133 | negative regulation of osteoblast proliferation (GO:0033689) | 2.67768793 |
| 134 | respiratory chain complex IV assembly (GO:0008535) | 2.67204985 |
| 135 | GDP-mannose metabolic process (GO:0019673) | 2.66357598 |
| 136 | endosome to pigment granule transport (GO:0043485) | 2.65577083 |
| 137 | endosome to melanosome transport (GO:0035646) | 2.65577083 |
| 138 | interferon-gamma production (GO:0032609) | 2.64960641 |
| 139 | detection of other organism (GO:0098543) | 2.64106578 |
| 140 | energy homeostasis (GO:0097009) | 2.57719307 |
| 141 | detection of bacterium (GO:0016045) | 2.57520574 |
| 142 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.56952738 |
| 143 | retinal cone cell development (GO:0046549) | 2.56919687 |
| 144 | regulation of activation of Janus kinase activity (GO:0010533) | 2.55563405 |
| 145 | GMP metabolic process (GO:0046037) | 2.52561073 |
| 146 | positive regulation of T cell migration (GO:2000406) | 2.50197769 |
| 147 | righting reflex (GO:0060013) | 2.48960955 |
| 148 | fucose metabolic process (GO:0006004) | 2.46925815 |
| 149 | dendritic cell migration (GO:0036336) | 2.46311733 |
| 150 | eosinophil migration (GO:0072677) | 2.46169055 |
| 151 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.44836628 |
| 152 | regulation of insulin secretion (GO:0050796) | 2.44630095 |
| 153 | negative regulation of norepinephrine secretion (GO:0010700) | 2.43692329 |
| 154 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.43261753 |
| 155 | response to pheromone (GO:0019236) | 2.42753787 |
| 156 | anterograde synaptic vesicle transport (GO:0048490) | 2.41699459 |
| 157 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.41282982 |
| 158 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.40576112 |
| 159 | GPI anchor biosynthetic process (GO:0006506) | 2.39943687 |
| 160 | positive regulation of defense response to virus by host (GO:0002230) | 2.39289849 |
| 161 | DNA strand renaturation (GO:0000733) | 2.38047145 |
| 162 | sequestering of metal ion (GO:0051238) | 2.34725560 |
| 163 | DNA deamination (GO:0045006) | 2.32879874 |
| 164 | detection of calcium ion (GO:0005513) | 2.31857351 |
| 165 | positive regulation of peptide hormone secretion (GO:0090277) | 2.31828971 |
| 166 | toxin transport (GO:1901998) | 2.31356074 |
| 167 | detection of chemical stimulus (GO:0009593) | 2.31320143 |
| 168 | regulation of peptide hormone secretion (GO:0090276) | 2.29751174 |
| 169 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.28865172 |
| 170 | regulation of axon regeneration (GO:0048679) | 2.28068777 |
| 171 | regulation of neuron projection regeneration (GO:0070570) | 2.28068777 |
| 172 | mannosylation (GO:0097502) | 2.27410913 |
| 173 | neutrophil activation involved in immune response (GO:0002283) | 2.26610369 |
| 174 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.26480169 |
| 175 | regulation of timing of cell differentiation (GO:0048505) | 2.26160286 |
| 176 | T cell migration (GO:0072678) | 2.26007629 |
| 177 | regulation of peptide secretion (GO:0002791) | 2.25225253 |
| 178 | protein K63-linked deubiquitination (GO:0070536) | 2.24853840 |
| 179 | negative regulation of catecholamine secretion (GO:0033604) | 2.24813160 |
| 180 | positive regulation of lymphocyte migration (GO:2000403) | 2.24801332 |
| 181 | glycosphingolipid catabolic process (GO:0046479) | 2.24784124 |
| 182 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.24560061 |
| 183 | ceramide catabolic process (GO:0046514) | 2.24087888 |
| 184 | developmental pigmentation (GO:0048066) | 2.23050210 |
| 185 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.22436670 |
| 186 | protein-chromophore linkage (GO:0018298) | 2.22025004 |
| 187 | intraciliary transport (GO:0042073) | 2.21846822 |
| 188 | lymph node development (GO:0048535) | 2.21042145 |
| 189 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.20799035 |
| 190 | regulation of hormone secretion (GO:0046883) | 2.20198678 |
| 191 | regulation of T cell migration (GO:2000404) | 2.19904377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.41676375 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.30712242 |
| 3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.29492041 |
| 4 | MYB_26560356_Chip-Seq_TH2_Human | 3.14672918 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.97437744 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.87884792 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.86914038 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69690883 |
| 9 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.65449388 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.63190875 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.60487799 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.44007598 |
| 13 | MYB_26560356_Chip-Seq_TH1_Human | 2.38222881 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.36998401 |
| 15 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.32665191 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.23096367 |
| 17 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.22578650 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.20301368 |
| 19 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18024102 |
| 20 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.17606706 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.16412754 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.13693793 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.13274108 |
| 24 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 2.05068859 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.01672684 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00234796 |
| 27 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.99184370 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.94037824 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.93987452 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93959051 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91209250 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.91195434 |
| 33 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.90859387 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.90301295 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87010662 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85580375 |
| 37 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.85284602 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83817350 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.79624886 |
| 40 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.79189073 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78526511 |
| 42 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.76755309 |
| 43 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.76074073 |
| 44 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.75517105 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.74971008 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.71626963 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.71022510 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.69646231 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68409934 |
| 50 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.64627970 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64529316 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64281304 |
| 53 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.62273836 |
| 54 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.62155861 |
| 55 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.60882255 |
| 56 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.60837036 |
| 57 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.60343060 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60248924 |
| 59 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.60157256 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58934009 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57890235 |
| 62 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.56263859 |
| 63 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.55982217 |
| 64 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.55553435 |
| 65 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.54872475 |
| 66 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.53588876 |
| 67 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.53181108 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52809826 |
| 69 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.51026532 |
| 70 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.49901294 |
| 71 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.49591754 |
| 72 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.48350425 |
| 73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46626898 |
| 74 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.45881645 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45473595 |
| 76 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.44989001 |
| 77 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.43984245 |
| 78 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.42797758 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42237516 |
| 80 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42232799 |
| 81 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.41099465 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40358405 |
| 83 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40242383 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.39475888 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.37655464 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37000984 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36365983 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.34759984 |
| 89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34717237 |
| 90 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34078595 |
| 91 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.33200022 |
| 92 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.32180989 |
| 93 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31199523 |
| 94 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.30697988 |
| 95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29542642 |
| 96 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.28949200 |
| 97 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28650610 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27153261 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27067574 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26474854 |
| 101 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24880270 |
| 102 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24408409 |
| 103 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23540741 |
| 104 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23406946 |
| 105 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23301334 |
| 106 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.20971455 |
| 107 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.20056892 |
| 108 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.19402926 |
| 109 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18427267 |
| 110 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15598976 |
| 111 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.14767087 |
| 112 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12558696 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12476452 |
| 114 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.11079218 |
| 115 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10967943 |
| 116 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08945326 |
| 117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.08468004 |
| 118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08461820 |
| 119 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07925520 |
| 120 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07295305 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07239682 |
| 122 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07149754 |
| 123 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05853788 |
| 124 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05135997 |
| 125 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04562454 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04170243 |
| 127 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.03992874 |
| 128 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.03211850 |
| 129 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02908236 |
| 130 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01840591 |
| 131 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01179745 |
| 132 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.00363089 |
| 133 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.00135683 |
| 134 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99849752 |
| 135 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99362592 |
| 136 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99029715 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98495356 |
| 138 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96719747 |
| 139 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96578638 |
| 140 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96004358 |
| 141 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95609727 |
| 142 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94763808 |
| 143 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93898480 |
| 144 | GATA3_26560356_Chip-Seq_TH1_Human | 0.93578096 |
| 145 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93061732 |
| 146 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93043035 |
| 147 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92863797 |
| 148 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92064178 |
| 149 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91617683 |
| 150 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90523377 |
| 151 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88095929 |
| 152 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86755591 |
| 153 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86750669 |
| 154 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.85149467 |
| 155 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83668677 |
| 156 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.81305271 |
| 157 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81075961 |
| 158 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79579855 |
| 159 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78994961 |
| 160 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.78654137 |
| 161 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77811874 |
| 162 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77780147 |
| 163 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.77424197 |
| 164 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77219577 |
| 165 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73414175 |
| 166 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72550539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006292_abnormal_olfactory_placode | 3.89504786 |
| 2 | MP0005379_endocrine/exocrine_gland_phen | 3.43829752 |
| 3 | MP0010386_abnormal_urinary_bladder | 3.36649095 |
| 4 | MP0002396_abnormal_hematopoietic_system | 3.23395099 |
| 5 | MP0006072_abnormal_retinal_apoptosis | 3.14605523 |
| 6 | MP0001986_abnormal_taste_sensitivity | 2.86205566 |
| 7 | MP0003303_peritoneal_inflammation | 2.83048313 |
| 8 | MP0005646_abnormal_pituitary_gland | 2.71130692 |
| 9 | MP0002693_abnormal_pancreas_physiology | 2.64325753 |
| 10 | MP0002638_abnormal_pupillary_reflex | 2.57564295 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.43023976 |
| 12 | MP0005551_abnormal_eye_electrophysiolog | 2.42217577 |
| 13 | MP0005671_abnormal_response_to | 2.40478974 |
| 14 | MP0005253_abnormal_eye_physiology | 2.40103025 |
| 15 | MP0001188_hyperpigmentation | 2.30923491 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 2.30721874 |
| 17 | MP0002163_abnormal_gland_morphology | 2.23550794 |
| 18 | MP0003195_calcinosis | 2.22662137 |
| 19 | MP0000678_abnormal_parathyroid_gland | 2.18294042 |
| 20 | MP0001944_abnormal_pancreas_morphology | 2.16165361 |
| 21 | MP0003724_increased_susceptibility_to | 2.15180888 |
| 22 | MP0005075_abnormal_melanosome_morpholog | 2.12091439 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.05803136 |
| 24 | MP0000689_abnormal_spleen_morphology | 1.99677653 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.99651424 |
| 26 | MP0004808_abnormal_hematopoietic_stem | 1.99022305 |
| 27 | MP0004043_abnormal_pH_regulation | 1.98745494 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.98306115 |
| 29 | MP0000015_abnormal_ear_pigmentation | 1.96907590 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.96218142 |
| 31 | MP0009785_altered_susceptibility_to | 1.95715370 |
| 32 | MP0002722_abnormal_immune_system | 1.93457727 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.93137637 |
| 34 | MP0001502_abnormal_circadian_rhythm | 1.80188472 |
| 35 | MP0005220_abnormal_exocrine_pancreas | 1.78621528 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.74686860 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.73565431 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.72317080 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.71017455 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.71017455 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.67583383 |
| 42 | MP0001873_stomach_inflammation | 1.65108436 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.58809774 |
| 44 | MP0009278_abnormal_bone_marrow | 1.58764139 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.58727822 |
| 46 | MP0003866_abnormal_defecation | 1.56792448 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.52311052 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.47696795 |
| 49 | MP0001790_abnormal_immune_system | 1.46804064 |
| 50 | MP0005387_immune_system_phenotype | 1.46804064 |
| 51 | MP0005310_abnormal_salivary_gland | 1.46501455 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.45757647 |
| 53 | MP0005025_abnormal_response_to | 1.42779125 |
| 54 | MP0001764_abnormal_homeostasis | 1.42201971 |
| 55 | MP0002006_tumorigenesis | 1.41577976 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.40437791 |
| 57 | MP0008058_abnormal_DNA_repair | 1.38747221 |
| 58 | MP0002723_abnormal_immune_serum | 1.38682510 |
| 59 | MP0000013_abnormal_adipose_tissue | 1.37326242 |
| 60 | MP0002102_abnormal_ear_morphology | 1.36243704 |
| 61 | MP0009697_abnormal_copulation | 1.35456959 |
| 62 | MP0002132_abnormal_respiratory_system | 1.35397469 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.32709955 |
| 64 | MP0002419_abnormal_innate_immunity | 1.32397445 |
| 65 | MP0008057_abnormal_DNA_replication | 1.32128049 |
| 66 | MP0003436_decreased_susceptibility_to | 1.31037019 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 1.29558593 |
| 68 | MP0003011_delayed_dark_adaptation | 1.24210313 |
| 69 | MP0001800_abnormal_humoral_immune | 1.23607714 |
| 70 | MP0001324_abnormal_eye_pigmentation | 1.19614953 |
| 71 | MP0001819_abnormal_immune_cell | 1.18602046 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 1.18562585 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.17330118 |
| 74 | MP0002452_abnormal_antigen_presenting | 1.16347992 |
| 75 | MP0004883_abnormal_blood_vessel | 1.14928832 |
| 76 | MP0004947_skin_inflammation | 1.12817972 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 1.12741938 |
| 78 | MP0003787_abnormal_imprinting | 1.08997101 |
| 79 | MP0004147_increased_porphyrin_level | 1.07074975 |
| 80 | MP0001984_abnormal_olfaction | 1.06166632 |
| 81 | MP0000566_synostosis | 1.05181695 |
| 82 | MP0008995_early_reproductive_senescence | 1.03416515 |
| 83 | MP0000613_abnormal_salivary_gland | 1.03327141 |
| 84 | MP0005257_abnormal_intraocular_pressure | 1.01291640 |
| 85 | MP0002938_white_spotting | 1.01216982 |
| 86 | MP0000681_abnormal_thyroid_gland | 1.00063772 |
| 87 | MP0003828_pulmonary_edema | 0.99478533 |
| 88 | MP0002928_abnormal_bile_duct | 0.98664675 |
| 89 | MP0005464_abnormal_platelet_physiology | 0.98654726 |
| 90 | MP0001851_eye_inflammation | 0.97783868 |
| 91 | MP0001663_abnormal_digestive_system | 0.95432472 |
| 92 | MP0002095_abnormal_skin_pigmentation | 0.94313813 |
| 93 | MP0000685_abnormal_immune_system | 0.94026489 |
| 94 | MP0003868_abnormal_feces_composition | 0.93815628 |
| 95 | MP0002398_abnormal_bone_marrow | 0.90732645 |
| 96 | MP0009764_decreased_sensitivity_to | 0.89789322 |
| 97 | MP0005166_decreased_susceptibility_to | 0.89633450 |
| 98 | MP0000716_abnormal_immune_system | 0.89263519 |
| 99 | MP0005423_abnormal_somatic_nervous | 0.88997357 |
| 100 | MP0000858_altered_metastatic_potential | 0.88123768 |
| 101 | MP0003191_abnormal_cellular_cholesterol | 0.88029026 |
| 102 | MP0005391_vision/eye_phenotype | 0.87391174 |
| 103 | MP0003045_fibrosis | 0.87363569 |
| 104 | MP0009763_increased_sensitivity_to | 0.87311283 |
| 105 | MP0002933_joint_inflammation | 0.87161591 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.87118246 |
| 107 | MP0009333_abnormal_splenocyte_physiolog | 0.86796495 |
| 108 | MP0001186_pigmentation_phenotype | 0.86583872 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.86270372 |
| 110 | MP0006082_CNS_inflammation | 0.85931386 |
| 111 | MP0005409_darkened_coat_color | 0.85706886 |
| 112 | MP0008007_abnormal_cellular_replicative | 0.83573381 |
| 113 | MP0008469_abnormal_protein_level | 0.80785521 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.80347959 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.79779626 |
| 116 | MP0003880_abnormal_central_pattern | 0.79644257 |
| 117 | MP0001853_heart_inflammation | 0.79146476 |
| 118 | MP0003448_altered_tumor_morphology | 0.79109870 |
| 119 | MP0004381_abnormal_hair_follicle | 0.78757023 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.78450206 |
| 121 | MP0002909_abnormal_adrenal_gland | 0.77928163 |
| 122 | MP0003136_yellow_coat_color | 0.77747396 |
| 123 | MP0005164_abnormal_response_to | 0.77650002 |
| 124 | MP0002138_abnormal_hepatobiliary_system | 0.77055748 |
| 125 | MP0002009_preneoplasia | 0.76997203 |
| 126 | MP0008961_abnormal_basal_metabolism | 0.75750116 |
| 127 | MP0002405_respiratory_system_inflammati | 0.75313331 |
| 128 | MP0003075_altered_response_to | 0.74592130 |
| 129 | MP0003786_premature_aging | 0.74535824 |
| 130 | MP0000490_abnormal_crypts_of | 0.73403711 |
| 131 | MP0003953_abnormal_hormone_level | 0.71917781 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.71811863 |
| 133 | MP0000538_abnormal_urinary_bladder | 0.70982032 |
| 134 | MP0005535_abnormal_body_temperature | 0.69844769 |
| 135 | MP0000465_gastrointestinal_hemorrhage | 0.69762682 |
| 136 | MP0008877_abnormal_DNA_methylation | 0.68243270 |
| 137 | MP0002429_abnormal_blood_cell | 0.67794874 |
| 138 | MP0005195_abnormal_posterior_eye | 0.67200006 |
| 139 | MP0000372_irregular_coat_pigmentation | 0.66443352 |
| 140 | MP0003252_abnormal_bile_duct | 0.66012836 |
| 141 | MP0003806_abnormal_nucleotide_metabolis | 0.65995282 |
| 142 | MP0003941_abnormal_skin_development | 0.65271954 |
| 143 | MP0006054_spinal_hemorrhage | 0.64970042 |
| 144 | MP0005390_skeleton_phenotype | 0.64260862 |
| 145 | MP0000249_abnormal_blood_vessel | 0.64008616 |
| 146 | MP0003943_abnormal_hepatobiliary_system | 0.61906546 |
| 147 | MP0000569_abnormal_digit_pigmentation | 0.56228372 |
| 148 | MP0008873_increased_physiological_sensi | 0.53957488 |
| 149 | MP0003795_abnormal_bone_structure | 0.52243478 |
| 150 | MP0001664_abnormal_digestion | 0.50683704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.98212205 |
| 2 | Panhypogammaglobulinemia (HP:0003139) | 4.76491378 |
| 3 | T lymphocytopenia (HP:0005403) | 4.67230524 |
| 4 | Congenital stationary night blindness (HP:0007642) | 4.44959761 |
| 5 | Abnormality of T cell number (HP:0011839) | 4.39795175 |
| 6 | Stomatitis (HP:0010280) | 4.20973321 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.19428589 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.00732854 |
| 9 | * Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.96955903 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 3.95067959 |
| 11 | Symptomatic seizures (HP:0011145) | 3.93228341 |
| 12 | Recurrent viral infections (HP:0004429) | 3.74265540 |
| 13 | * Abnormal rod and cone electroretinograms (HP:0008323) | 3.74225242 |
| 14 | Abnormality of T cells (HP:0002843) | 3.71053778 |
| 15 | Type I transferrin isoform profile (HP:0003642) | 3.68752477 |
| 16 | Decreased central vision (HP:0007663) | 3.65383673 |
| 17 | Hypoglycemic seizures (HP:0002173) | 3.65302424 |
| 18 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.51549252 |
| 19 | Hypoplasia of the fovea (HP:0007750) | 3.51549252 |
| 20 | Abnormality of B cell number (HP:0010975) | 3.50615319 |
| 21 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.49477338 |
| 22 | Agammaglobulinemia (HP:0004432) | 3.48427745 |
| 23 | Recurrent skin infections (HP:0001581) | 3.42308217 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 3.37803403 |
| 25 | Severe visual impairment (HP:0001141) | 3.27543903 |
| 26 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.25426258 |
| 27 | B lymphocytopenia (HP:0010976) | 3.23443444 |
| 28 | Vasculitis (HP:0002633) | 3.22250772 |
| 29 | Abnormality of eosinophils (HP:0001879) | 3.21304630 |
| 30 | Acute lymphatic leukemia (HP:0006721) | 3.20622664 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 3.20482284 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.20069950 |
| 33 | Obstructive lung disease (HP:0006536) | 3.20069950 |
| 34 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.19167820 |
| 35 | Thyroiditis (HP:0100646) | 3.16210238 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.14669219 |
| 37 | True hermaphroditism (HP:0010459) | 3.13757652 |
| 38 | Leukocytosis (HP:0001974) | 3.11735598 |
| 39 | Optic neuritis (HP:0100653) | 3.09056722 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 3.09056722 |
| 41 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.06857960 |
| 42 | Absent/shortened dynein arms (HP:0200106) | 3.06857960 |
| 43 | Decreased circulating renin level (HP:0003351) | 3.05746395 |
| 44 | Combined immunodeficiency (HP:0005387) | 3.02337333 |
| 45 | Pendular nystagmus (HP:0012043) | 3.01730823 |
| 46 | Abnormality of macrophages (HP:0004311) | 3.01330826 |
| 47 | Granulocytopenia (HP:0001913) | 2.98336438 |
| 48 | Abnormality of the prostate (HP:0008775) | 2.95488441 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.95248671 |
| 50 | IgG deficiency (HP:0004315) | 2.94905952 |
| 51 | Abnormality of the fovea (HP:0000493) | 2.94275425 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.91472997 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.89558210 |
| 54 | Abnormal protein glycosylation (HP:0012346) | 2.86950409 |
| 55 | Abnormal glycosylation (HP:0012345) | 2.86950409 |
| 56 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.86950409 |
| 57 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.86950409 |
| 58 | Eosinophilia (HP:0001880) | 2.86353685 |
| 59 | Myositis (HP:0100614) | 2.83565796 |
| 60 | Epistaxis (HP:0000421) | 2.82710164 |
| 61 | Chronic otitis media (HP:0000389) | 2.81824666 |
| 62 | Pustule (HP:0200039) | 2.80421431 |
| 63 | Hypothermia (HP:0002045) | 2.78477749 |
| 64 | Hypoplasia of the thymus (HP:0000778) | 2.78009131 |
| 65 | Recurrent bronchitis (HP:0002837) | 2.77197409 |
| 66 | Osteomalacia (HP:0002749) | 2.75293819 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.74538095 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.71972434 |
| 69 | Hemoptysis (HP:0002105) | 2.71934040 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.70831048 |
| 71 | * Attenuation of retinal blood vessels (HP:0007843) | 2.70391683 |
| 72 | Chest pain (HP:0100749) | 2.68031658 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.64163513 |
| 74 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.62395324 |
| 75 | Pancreatic cysts (HP:0001737) | 2.59315139 |
| 76 | Pulmonary embolism (HP:0002204) | 2.59269594 |
| 77 | Pancreatic fibrosis (HP:0100732) | 2.57810387 |
| 78 | Orchitis (HP:0100796) | 2.57718478 |
| 79 | Dyschromatopsia (HP:0007641) | 2.57537115 |
| 80 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.55671101 |
| 81 | Abnormality of macular pigmentation (HP:0008002) | 2.53535546 |
| 82 | Recurrent sinusitis (HP:0011108) | 2.50475255 |
| 83 | IgM deficiency (HP:0002850) | 2.50128821 |
| 84 | Papilledema (HP:0001085) | 2.47755873 |
| 85 | Urticaria (HP:0001025) | 2.46487282 |
| 86 | Vacuolated lymphocytes (HP:0001922) | 2.46399209 |
| 87 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.42962482 |
| 88 | Arterial thrombosis (HP:0004420) | 2.41011524 |
| 89 | Chromsome breakage (HP:0040012) | 2.37943528 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.37776909 |
| 91 | Abnormal ciliary motility (HP:0012262) | 2.35159414 |
| 92 | Gingival bleeding (HP:0000225) | 2.34629211 |
| 93 | Hypoglycemic coma (HP:0001325) | 2.34312335 |
| 94 | Intestinal atresia (HP:0011100) | 2.33434062 |
| 95 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.32225408 |
| 96 | Renal cortical cysts (HP:0000803) | 2.30089964 |
| 97 | Congenital sensorineural hearing impairment (HP:0008527) | 2.29365510 |
| 98 | Increased IgE level (HP:0003212) | 2.29220524 |
| 99 | Lymphopenia (HP:0001888) | 2.28915211 |
| 100 | Increased corneal curvature (HP:0100692) | 2.28751199 |
| 101 | Keratoconus (HP:0000563) | 2.28751199 |
| 102 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.26808992 |
| 103 | Colitis (HP:0002583) | 2.26075513 |
| 104 | Bronchiectasis (HP:0002110) | 2.24649650 |
| 105 | Microvesicular hepatic steatosis (HP:0001414) | 2.24217070 |
| 106 | Thrombocytosis (HP:0001894) | 2.24161792 |
| 107 | Hypochromic microcytic anemia (HP:0004840) | 2.21849670 |
| 108 | Hypoproteinemia (HP:0003075) | 2.21028009 |
| 109 | Chronic diarrhea (HP:0002028) | 2.20513395 |
| 110 | Cellulitis (HP:0100658) | 2.19278749 |
| 111 | Microcytic anemia (HP:0001935) | 2.19182062 |
| 112 | Petechiae (HP:0000967) | 2.18011070 |
| 113 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.17863683 |
| 114 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.17863683 |
| 115 | Central scotoma (HP:0000603) | 2.17632285 |
| 116 | Conjugated hyperbilirubinemia (HP:0002908) | 2.16726149 |
| 117 | Bronchitis (HP:0012387) | 2.14555090 |
| 118 | Chronic sinusitis (HP:0011109) | 2.12726631 |
| 119 | Episodic fever (HP:0001954) | 2.11959434 |
| 120 | Abolished electroretinogram (ERG) (HP:0000550) | 2.11741104 |
| 121 | Hyperglycemia (HP:0003074) | 2.11619550 |
| 122 | Lymphoma (HP:0002665) | 2.11271128 |
| 123 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.10607920 |
| 124 | Anorexia (HP:0002039) | 2.09835165 |
| 125 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.09600943 |
| 126 | Albinism (HP:0001022) | 2.08615933 |
| 127 | * Photophobia (HP:0000613) | 2.08010332 |
| 128 | Aplastic anemia (HP:0001915) | 2.07051041 |
| 129 | Acute myeloid leukemia (HP:0004808) | 2.06685082 |
| 130 | Acute hepatic failure (HP:0006554) | 2.04086051 |
| 131 | Cystic liver disease (HP:0006706) | 2.03369592 |
| 132 | Medial flaring of the eyebrow (HP:0010747) | 2.03096816 |
| 133 | Abnormality of the pleura (HP:0002103) | 2.03044973 |
| 134 | Encephalitis (HP:0002383) | 2.02681204 |
| 135 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.01912770 |
| 136 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.01459848 |
| 137 | Sepsis (HP:0100806) | 2.00938294 |
| 138 | Skin rash (HP:0000988) | 2.00270609 |
| 139 | Hypochromic anemia (HP:0001931) | 1.99895341 |
| 140 | Metaphyseal dysplasia (HP:0100255) | 1.99779123 |
| 141 | Hypergammaglobulinemia (HP:0010702) | 1.97626745 |
| 142 | Generalized aminoaciduria (HP:0002909) | 1.96520439 |
| 143 | Nasal polyposis (HP:0100582) | 1.95445935 |
| 144 | Joint hemorrhage (HP:0005261) | 1.94070612 |
| 145 | Meningitis (HP:0001287) | 1.91858619 |
| 146 | Generalized hypopigmentation of hair (HP:0011358) | 1.90684696 |
| 147 | Keratoconjunctivitis sicca (HP:0001097) | 1.90377062 |
| 148 | Pigmentary retinal degeneration (HP:0001146) | 1.89075422 |
| 149 | Recurrent abscess formation (HP:0002722) | 1.88769011 |
| 150 | Dysostosis multiplex (HP:0000943) | 1.85882856 |
| 151 | Prolonged partial thromboplastin time (HP:0003645) | 1.85741135 |
| 152 | 11 pairs of ribs (HP:0000878) | 1.84719165 |
| 153 | Fair hair (HP:0002286) | 1.84366995 |
| 154 | * Type II diabetes mellitus (HP:0005978) | 1.84313754 |
| 155 | Congenital hepatic fibrosis (HP:0002612) | 1.84206584 |
| 156 | * Constricted visual fields (HP:0001133) | 1.83608335 |
| 157 | Increased hepatocellular lipid droplets (HP:0006565) | 1.82500492 |
| 158 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.79929656 |
| 159 | Chronic hepatic failure (HP:0100626) | 1.79251564 |
| 160 | Recurrent bacterial skin infections (HP:0005406) | 1.78197717 |
| 161 | Prominent metopic ridge (HP:0005487) | 1.77633210 |
| 162 | Retinitis pigmentosa (HP:0000510) | 1.76783533 |
| 163 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.75567577 |
| 164 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.75567577 |
| 165 | Neutropenia (HP:0001875) | 1.74871057 |
| 166 | Prolonged bleeding time (HP:0003010) | 1.74448373 |
| 167 | Recurrent cutaneous fungal infections (HP:0011370) | 1.73925539 |
| 168 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.73925539 |
| 169 | 3-Methylglutaconic aciduria (HP:0003535) | 1.73736423 |
| 170 | Clubbing of toes (HP:0100760) | 1.73440889 |
| 171 | Renal Fanconi syndrome (HP:0001994) | 1.72258461 |
| 172 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72217855 |
| 173 | Limb hypertonia (HP:0002509) | 1.72049141 |
| 174 | Exertional dyspnea (HP:0002875) | 1.70754264 |
| 175 | Keratoconjunctivitis (HP:0001096) | 1.70578626 |
| 176 | Abnormality of midbrain morphology (HP:0002418) | 1.69681869 |
| 177 | Molar tooth sign on MRI (HP:0002419) | 1.69681869 |
| 178 | Cone-rod dystrophy (HP:0000548) | 1.68356633 |
| 179 | Febrile seizures (HP:0002373) | 1.68001785 |
| 180 | Increased IgM level (HP:0003496) | 1.67285359 |
| 181 | Abnormality of renal resorption (HP:0011038) | 1.67042091 |
| 182 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.66124588 |
| 183 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.66124588 |
| 184 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.66124588 |
| 185 | Mucopolysacchariduria (HP:0008155) | 1.65357271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.34285000 |
| 2 | IRAK3 | 3.66530155 |
| 3 | IRAK4 | 3.14873766 |
| 4 | MAPK15 | 3.08436630 |
| 5 | STK16 | 2.91137435 |
| 6 | PASK | 2.56102581 |
| 7 | TNIK | 2.38296013 |
| 8 | TAOK3 | 2.32747104 |
| 9 | TXK | 2.27545668 |
| 10 | CDK8 | 2.22378624 |
| 11 | MAP2K3 | 2.22059190 |
| 12 | MAP3K14 | 2.13704062 |
| 13 | ADRBK2 | 2.04559801 |
| 14 | GRK6 | 1.94472890 |
| 15 | TEC | 1.92468538 |
| 16 | BCKDK | 1.89816593 |
| 17 | MATK | 1.86349445 |
| 18 | TRPM7 | 1.84429195 |
| 19 | PIK3CG | 1.84269807 |
| 20 | CDK19 | 1.83125007 |
| 21 | GRK1 | 1.82536124 |
| 22 | BMPR2 | 1.74826557 |
| 23 | IRAK1 | 1.72079554 |
| 24 | WNK3 | 1.68238914 |
| 25 | CASK | 1.65406491 |
| 26 | GRK7 | 1.63564140 |
| 27 | BMPR1B | 1.61114251 |
| 28 | EIF2AK2 | 1.55395401 |
| 29 | CSF1R | 1.53867046 |
| 30 | HCK | 1.52877145 |
| 31 | HIPK2 | 1.52151730 |
| 32 | ZAK | 1.35229885 |
| 33 | SIK3 | 1.32779024 |
| 34 | NLK | 1.32117739 |
| 35 | BTK | 1.30133661 |
| 36 | VRK1 | 1.28860075 |
| 37 | MAP2K7 | 1.26556403 |
| 38 | JAK3 | 1.26176251 |
| 39 | EPHA3 | 1.22298808 |
| 40 | KIT | 1.21107460 |
| 41 | IRAK2 | 1.20626378 |
| 42 | YES1 | 1.18835428 |
| 43 | BLK | 1.17914499 |
| 44 | IKBKE | 1.17808780 |
| 45 | EIF2AK3 | 1.16189746 |
| 46 | PRKCQ | 1.12153816 |
| 47 | MARK3 | 1.09466439 |
| 48 | BRSK2 | 1.06446485 |
| 49 | CDK3 | 1.04760764 |
| 50 | NTRK3 | 1.02853026 |
| 51 | FLT3 | 1.02843229 |
| 52 | IKBKB | 1.02377230 |
| 53 | SGK2 | 0.98593199 |
| 54 | JAK2 | 0.94985632 |
| 55 | MUSK | 0.93280864 |
| 56 | SCYL2 | 0.92285199 |
| 57 | CDK6 | 0.90732845 |
| 58 | ERN1 | 0.90441417 |
| 59 | ITK | 0.83972363 |
| 60 | SYK | 0.83872250 |
| 61 | CDK9 | 0.80521766 |
| 62 | NUAK1 | 0.79226813 |
| 63 | CHUK | 0.78567537 |
| 64 | TESK2 | 0.77110303 |
| 65 | PINK1 | 0.77064882 |
| 66 | MAPK7 | 0.76973334 |
| 67 | MAPK13 | 0.76597299 |
| 68 | NME2 | 0.76585762 |
| 69 | LYN | 0.76550628 |
| 70 | CAMKK2 | 0.74455954 |
| 71 | DYRK3 | 0.74088736 |
| 72 | PDK1 | 0.73720332 |
| 73 | RIPK4 | 0.72794725 |
| 74 | ERBB3 | 0.70761685 |
| 75 | MAP3K6 | 0.70520205 |
| 76 | TNK2 | 0.69796836 |
| 77 | FGFR3 | 0.69167343 |
| 78 | TIE1 | 0.67959629 |
| 79 | KDR | 0.60975116 |
| 80 | MAP3K7 | 0.60472256 |
| 81 | MAP3K13 | 0.59576891 |
| 82 | PIM2 | 0.57420994 |
| 83 | PRKD2 | 0.57356093 |
| 84 | MKNK2 | 0.55958217 |
| 85 | PRPF4B | 0.55897439 |
| 86 | MAP4K1 | 0.55641146 |
| 87 | AKT3 | 0.53572376 |
| 88 | BRD4 | 0.53403156 |
| 89 | MAP3K3 | 0.53151192 |
| 90 | ZAP70 | 0.52746190 |
| 91 | PLK4 | 0.52165928 |
| 92 | CSK | 0.51001083 |
| 93 | ABL1 | 0.50962087 |
| 94 | MAP4K2 | 0.50268191 |
| 95 | MAPK12 | 0.50008763 |
| 96 | MAP2K6 | 0.49686116 |
| 97 | FRK | 0.48932478 |
| 98 | LCK | 0.48672595 |
| 99 | JAK1 | 0.48023886 |
| 100 | MST4 | 0.47972288 |
| 101 | TGFBR2 | 0.47253485 |
| 102 | RPS6KA5 | 0.46433708 |
| 103 | FGR | 0.45938592 |
| 104 | FYN | 0.45563468 |
| 105 | STK10 | 0.45480668 |
| 106 | PRKCH | 0.45096453 |
| 107 | ATR | 0.43965523 |
| 108 | NEK6 | 0.43642172 |
| 109 | SRPK1 | 0.43427845 |
| 110 | TBK1 | 0.43236037 |
| 111 | MAP3K1 | 0.42806519 |
| 112 | MAP2K2 | 0.42524062 |
| 113 | MAP3K5 | 0.42293070 |
| 114 | FES | 0.42151413 |
| 115 | WNK4 | 0.41811665 |
| 116 | RPS6KA6 | 0.41717593 |
| 117 | CLK1 | 0.41419087 |
| 118 | CDK4 | 0.41272532 |
| 119 | DAPK2 | 0.40873569 |
| 120 | RPS6KL1 | 0.40604989 |
| 121 | RPS6KC1 | 0.40604989 |
| 122 | PRKCE | 0.40551702 |
| 123 | RPS6KA4 | 0.40345329 |
| 124 | CAMKK1 | 0.39822163 |
| 125 | TYK2 | 0.39755498 |
| 126 | SGK494 | 0.39364999 |
| 127 | SGK223 | 0.39364999 |
| 128 | CAMK1 | 0.39155521 |
| 129 | RPS6KB1 | 0.38406913 |
| 130 | MAP3K11 | 0.38313248 |
| 131 | STK38L | 0.37503390 |
| 132 | MAPK4 | 0.36983089 |
| 133 | STK11 | 0.35734252 |
| 134 | SGK3 | 0.35536795 |
| 135 | RPS6KB2 | 0.34520643 |
| 136 | WNK1 | 0.33428005 |
| 137 | MKNK1 | 0.33319214 |
| 138 | TLK1 | 0.33003252 |
| 139 | BRAF | 0.32920805 |
| 140 | OXSR1 | 0.32740087 |
| 141 | RPS6KA2 | 0.32575813 |
| 142 | PDPK1 | 0.31794817 |
| 143 | INSR | 0.31582470 |
| 144 | PIM1 | 0.31286705 |
| 145 | ACVR1B | 0.31145739 |
| 146 | PRKCD | 0.30979219 |
| 147 | PTK2B | 0.30804231 |
| 148 | MAPK3 | 0.30597322 |
| 149 | MAPK11 | 0.28090501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.03418383 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.38594117 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.49149399 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.31288630 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.24968803 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.24004050 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.17074816 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02104308 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98331237 |
| 10 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.88480445 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 1.70379608 |
| 12 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.64250294 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.60308354 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.58517082 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53793875 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.52120233 |
| 17 | Platelet activation_Homo sapiens_hsa04611 | 1.45584367 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.44886438 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.44801530 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44783948 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40905292 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38181846 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.37959632 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.36122514 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33262692 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31942795 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31879985 |
| 28 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.31743778 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31507890 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30566580 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.28982136 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27663963 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.24630041 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.20381751 |
| 35 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.18981423 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17839036 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.17066202 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.15314013 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.14725239 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14622640 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13786840 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10839381 |
| 43 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.08856860 |
| 44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07665237 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.07664509 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06944166 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05925191 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05067671 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01860875 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 1.00757211 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95987113 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91857586 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90541952 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90028555 |
| 55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88604589 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88357309 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88206820 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.88019629 |
| 59 | Mismatch repair_Homo sapiens_hsa03430 | 0.85609529 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85222547 |
| 61 | Base excision repair_Homo sapiens_hsa03410 | 0.85196300 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85099026 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85027198 |
| 64 | Purine metabolism_Homo sapiens_hsa00230 | 0.84643771 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84533342 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.80407478 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79509285 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79277154 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78366495 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75649280 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.75270592 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74805099 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.73384433 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72263698 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71265475 |
| 76 | Morphine addiction_Homo sapiens_hsa05032 | 0.70032619 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.68535622 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68295069 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67689267 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67052235 |
| 81 | Legionellosis_Homo sapiens_hsa05134 | 0.65464815 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65032233 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63027747 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61927095 |
| 85 | Nicotine addiction_Homo sapiens_hsa05033 | 0.61814137 |
| 86 | DNA replication_Homo sapiens_hsa03030 | 0.61442048 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61432368 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61048095 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59141500 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58414825 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57370686 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56007152 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55998583 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54808768 |
| 95 | Ribosome_Homo sapiens_hsa03010 | 0.54357327 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53927772 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.53411374 |
| 98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52676114 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52119541 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.51662750 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51225572 |
| 102 | Circadian entrainment_Homo sapiens_hsa04713 | 0.51218241 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50371756 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50057782 |
| 105 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49132764 |
| 106 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48968665 |
| 107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.48096985 |
| 108 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.45632464 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.45273752 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44562320 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44473493 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44282018 |
| 113 | Shigellosis_Homo sapiens_hsa05131 | 0.43389790 |
| 114 | Renin secretion_Homo sapiens_hsa04924 | 0.43252803 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42758868 |
| 116 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.42589733 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.41767553 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41021322 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41007442 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40803443 |
| 121 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40427787 |
| 122 | Peroxisome_Homo sapiens_hsa04146 | 0.40135962 |
| 123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40027440 |
| 124 | Salivary secretion_Homo sapiens_hsa04970 | 0.39295618 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38217088 |
| 126 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37040251 |
| 127 | Phagosome_Homo sapiens_hsa04145 | 0.36699763 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36419142 |
| 129 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35945912 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.35472866 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35419312 |
| 132 | GABAergic synapse_Homo sapiens_hsa04727 | 0.33986481 |
| 133 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33620976 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32926783 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31489494 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28594304 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28130865 |
| 138 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27431598 |
| 139 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27079641 |
| 140 | Hepatitis B_Homo sapiens_hsa05161 | 0.26308119 |
| 141 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25596147 |
| 142 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.25487591 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21503663 |
| 144 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21160889 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20117795 |
| 146 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19719623 |
| 147 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18445472 |
| 148 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.18091342 |

